A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/415 (2006.01)
Patent
CA 2620923
Methods for treating or preventing atherosclerosis in human or non-human animal subjects by inhibiting or blocking intermediate-conductance calcium activated potassium channels associated with vascular smooth muscle and/or other cells which play a role in the pathogenesis of atherosclerosis (e.g., KCa3.1, KCNN4, IKCa1, IK1, SK4 channels).
L'invention concerne des méthodes permettant de traiter ou de prévenir l'athérosclérose chez des sujets humains ou des animaux non humains par inhibition ou blocage de canaux potassiques activés par le calcium de conductance intermédiaire associés à un muscle lisse vasculaire et/ou à d'autres cellules qui jouent un rôle dans la pathogénèse de l'athérosclérose (par exemple, les canaux KCa3.1, KCNN4, IKCa1, IK1, SK4).
George Chandy K.
Miura Hiroto
Wulff Heike
Gowling Lafleur Henderson Llp
Mcw Research Foundation Inc.
The Regents Of The University Of California
LandOfFree
Inhibition of intermediate-conductance calcium activated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of intermediate-conductance calcium activated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of intermediate-conductance calcium activated... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1774177